drugset
drugset / Trial / NCT05124314

Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss

NCT05124314 ↗

Phase 4 Unknown 220 enrolled Clinical Hospital Merkur University of Zagreb · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the safety and efficacy of a combination of two drugs (mifepristone and misoprostol) to only one of these drugs (misoprostol) in medical management of missed miscarriage up to 13+6 weeks of pregnancy (early pregnancy loss). The investigators aim to enroll 220 patients within two years which would be enough to determine the difference between these two treatments with confidence.

Timeline

Start
2021-10-27
Primary completion
2023-10
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 600 mg Oral
Subject Misoprostol Other / unclassified 800 ug Intravenous

Indications

No indication recorded.